Total Lab Automation Market projected to reach USD 8.1 Billion by 2030, growing at a CAGR of 6.5% during the forecast period of 2023-2030 – says MarketDigits in its latest study

The Global Total Lab Automation Market was valued USD 5.2 Billion in 2023 and projected to reach USD 8.1 Billion by 2030, growing at a CAGR of 6.5% during the forecast period of 2023-2030

Richmond, Jan. 03, 2024 (GLOBE NEWSWIRE) — According to a research report Total Lab Automation Market, by Type (Software, Equipment), Application (On-premise, Cloud), End User (Pharmaceutical Companies, Hospitals and Diagnostic Centers, Educational Institutions, Contract Research Organizations (CROs), Research Institutes), Application (Proteomics, Protein Engineering, Genomics, Drug Discovery, Clinical Diagnostics, Bio-analysis, Analytical Chemistry) and Region – Global Forecast to 2030.

Global Total Lab Automation Market Report Scope:

Report Details
Market size value in 2023 USD 5.2 Billion
Market size value in 2030 USD 8.1 Billion
CAGR (2023-2030) 6.5%
Forecast Period 2023–2030
Historic Data 2019
Forecast Units Value (USD Million/USD Billion)
Segments Covered Type, Application, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and RoW
 
  • Thermo Fisher Scientific Inc, , ,
 
  • Siemens Healthineers AG
Sample of Companies Covered
  • Agilent Technologies, Inc.
 
  • PerkinElmer, Inc
 
  • Roche Diagnostics

Download the Samplehttps://www.marketdigits.com/request/sample/3783

TOC Covers in Depth & Breath on Total Lab Automation Market
170 – Market Data Tables
65 – List of Figures
225 – Pages

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Equipment, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits. View detailed Table of Content here

Market Overview

The global Total Lab Automation market has emerged as a key factor in revolutionizing various industries by offering innovative solutions to long-standing challenges. The total lab automation is based on the increasing demand for streamlined and efficient laboratory processes across various industries. This market revolves around the adoption of automated systems and technologies to perform tasks traditionally carried out by humans in laboratories.

The Total Laboratory automated (TLA) is used in the laboratory to carry out extremely repetitive activities. Robotic equipment generally takes the place of human operators in the preparation and transportation of specimens. Also the automation in the laboratory allows fewer people to handle the control of several distinct analytical instruments which in turn reduces the price of laboratory testing.

With the huge database it might be able to forecast cancer. The recent release of a new cancer protein profile database assembled using artificial intelligence (AI) and machine learning has given cancer prediction medicine a boost. The proteome signature in cancer patient blood is mapped for the first time with the help of the recently released open-access Disease Blood Atlas.

Also The Human Protein Atlas consortium2, housed within SciLifeLab, a collaborative research center comprising KTH Royal Institute of Technology, Uppsala University, Karolinska Institutet, and Stockholm University, all in Sweden, has created a new database that showcases 1,463 proteins linked to 12 distinct cancer types. Additionally, the database presents proteins that can be utilized to distinguish between distinct cancer types based on a drop of blood.

Additionally the information compiled by The Disease Blood Atlas is able to measure the minute amounts of blood plasma at the time of diagnosis and before the treatment. This blood samples have undergone a statistical analysis of the gene expressions and machine learning based disease predictions.

Major Vendors in the Global Total Lab Automation Market:

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Roche Diagnostics
  • Abbott Laboratories
  • Hamilton Company
  • Bio-Rad Laboratories, Inc.
  • Hudson Robotics Inc

Request for Discount @ https://www.marketdigits.com/request/discount/3783

Advancements in Total Lab Automation

The recent release of a new cancer protein profile database assembled using artificial intelligence (AI) and machine learning has given cancer prediction medicine a boost. The proteome signature in cancer patient blood is mapped for the first time with the help of the recently released open-access Disease Blood Atlas.

The Human Protein Atlas consortium2, housed within SciLifeLab, a collaborative research center comprising KTH Royal Institute of Technology, Uppsala University, Karolinska Institutet, and Stockholm University, all in Sweden, has created a new database that showcases 1,463 proteins linked to 12 distinct cancer types. Additionally, the database presents proteins that can be utilized to distinguish between distinct cancer types based on a drop of blood.

Market Dynamics

Drivers:

  • Cost Savings.
  • Data Management
  • High Throughput Screening
  • Lab automation helps in reducing operational costs by optimizing resource utilization.
  • Performing of tedious task like chromatography and filtration faster and more consistently than manual methods.

Opportunities:

  • The growing interest in personalized medicine, tailored to individual patient profiles, creates opportunities for lab automation
  • Lab automation presents growth prospects in environmental testing, helping to analyze and monitor air, water, and soil quality.
  • Streamlining workflows in pathology through automation can improve the productivity of clinical and molecular pathology laboratories by handling tasks including sample preparation, staining, and imaging.
  • Quality assurance and control in pharmaceutical manufacture, lab automation is essential. Pharmaceutical items are consistently of a high quality thanks to the standardization of production processes facilitated by automated technologies.
  • The integration of emerging technologies, such as artificial intelligence and robotics, into lab automation systems opens up new growth opportunities.

Rising Demand for Total Lab Automations in Protein Engineering

The increasing adoption of Total Lab Automations assist in S Protein design and library creation applications is a significant driver for the market’s growth. The Automated DNA synthesis and manipulation can be easily done with the same. Moreover robots can precisely and efficiently assemble complex genes for the desired protein variants accurately. Additionally TLA platforms can perform multiple protein expression and assay cycles in parallel, rapidly identifying optimal protein variations. Moreover with the addition of robots the tedious tasks such as chromatography and filtration can be done more consistently and precisely using manual methods.

Protein expression and purification: Automated growth and fermentation: TLA systems can manage multiple bioreactors and control growth conditions with precision, optimizing protein production.

North America dominates the market for Total Lab Automation.

North America dominates the global total lab automation market specifically United States, emerging as the dominating region in the global Total Lab Automation market. The region’s dominance can be attributed to the presence of key market players, robust research and development activities, and favorable regulatory frameworks that encourage the testing and Application of Total Lab Automation technologies. Moreover U.S. being home to the several advanced manufacturers along with the established infrastructure has led towards the growth and development in the region. Also The U.S., with the established infrastructure, supportive policies and conducive environment for technological innovation, leads in the adoption of Total Lab Automation solutions across diverse sectors.

Asia-Pacific, exhibits high growth potential in the Total Lab Automation market due to the advancements in healthcare facilities along with the favorable healthcare policies and support from the government in the region. Moreover the region is home to about 60% of the global population and India and China being the two most populated countries. Also the market is mostly driven by the region’s growing number of medical centers with cutting-edge laboratories and better healthcare facilities. In addition, modular laboratories have become popular due to the technological advancement in the biomedical and pharmaceutical fields, providing a dependable and affordable alternative. Additionally, in an effort to lower input costs and speed up tests in automated laboratories, the governments in the region’s are funding R&D projects.

The Application Segment is anticipated to hold the Largest Market Share during the Forecast Period

In the global Total Lab Automation market in, the Application segment is categorized into Proteomics , Protein Engineering ,Genomics ,Drug Discovery ,Clinical Diagnostics ,Bio-analysis and Analytical Chemistry.  The protein engineering held the largest market share. With this method the robots can separate the proteins from different cellular ingredients using filters and strainers. Additionally they can use their blueprints (DNA) to precisely create different versions of proteins, like adding or swapping ingredients to change their properties. This increases the discovery of new proteins for drugs, therapies, and materials. Also the handling of hazardous and infectious substances has become convenient for lab workers and professionals.

Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3783

Browse Similar Reports:

Clinical Microbiology Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Clinical Oncology Next-generation Sequencing Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Clinical Trials Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy